D

DJS Antibodies

15 employees

DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
GPCRs
Therapeutics
Antibodies

Date founded

2014

Funding rounds raised

Total raised

$8.1M

from 5 investors over 5 rounds

D

DJS Antibodies raised $8.1M on December 22, 2020

Investors: Oxford Sciences Innovation

D

DJS Antibodies raised undisclosed on April 1, 2019

Investors: Innovate UK

D

DJS Antibodies raised undisclosed on October 5, 2016

Investors: Oxford Sciences Innovation

D

DJS Antibodies raised undisclosed on November 1, 2015

Investors: Innovate UK

D

DJS Antibodies raised undisclosed on May 20, 2015

Investors: Bizkaiko Foru Aldundia

FAQ